{"id":"https://openalex.org/W2118664840","doi":"https://doi.org/10.3810/pgm.2010.05.2149","title":"Exenatide is Non-inferior to Insulin in Reducing HbA 1c : An Integrated Analysis of 1423 Patients with Type 2 Diabetes","display_name":"Exenatide is Non-inferior to Insulin in Reducing HbA 1c : An Integrated Analysis of 1423 Patients with Type 2 Diabetes","alternate_titles":[],"publication_year":2010,"publication_date":"2010-05-01","ids":{"openalex":"https://openalex.org/W2118664840","doi":"https://doi.org/10.3810/pgm.2010.05.2149","mag":"2118664840","pmid":"https://pubmed.ncbi.nlm.nih.gov/20463421"},"language":"en","primary_location":{"id":"doi:10.3810/pgm.2010.05.2149","doi":"https://doi.org/10.3810/pgm.2010.05.2149","is_oa":false,"landing_page_url":"https://doi.org/10.3810/pgm.2010.05.2149","pdf_url":null,"source":{"id":"https://openalex.org/S11800902","display_name":"Postgraduate Medicine","issn_l":"0032-5481","issn":["0032-5481","1941-9260"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Postgraduate Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2118664840"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004471830","display_name":"Thomas Blevins","orcid":"https://orcid.org/0000-0003-3746-9606","observed_orcids":["https://orcid.org/0000-0003-3746-9606"]},"institutions":[{"id":"https://openalex.org/I4210135305","display_name":"Texas Diabetes & Endocrinology","ror":"https://ror.org/034cxfp17","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210135305"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Blevins","raw_affiliation_strings":["Texas Diabetes and Endocrinology, P.A., Austin, TX","Texas Diabetes and Endocrinology, P.A., Austin, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Diabetes and Endocrinology, P.A., Austin, TX","institution_ids":["https://openalex.org/I4210135305"]},{"raw_affiliation_string":"Texas Diabetes and Endocrinology, P.A., Austin, TX, USA","institution_ids":["https://openalex.org/I4210135305"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111694431","display_name":"Jenny Han","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jenny Han","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036735551","display_name":"Dawn Nicewarner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Dawn Nicewarner","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019481845","display_name":"Steve Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steve Chen","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103851824","display_name":"Juliana H. Oliveira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juliana H. A. Oliveira","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113643367","display_name":"Stephen L. Aronoff","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Aronoff","raw_affiliation_strings":["Endocrine Associates of Dallas, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrine Associates of Dallas, Dallas, TX","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5036735551"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.0305,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.91012335,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"122","issue":"3","first_page":"118","last_page":"128"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":1.0},{"id":"https://openalex.org/keywords/insulin","display_name":"insulin","score":0.9769999980926514},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9959999918937683},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9390000104904175},{"id":"https://openalex.org/keywords/hba1c-reduction","display_name":"HbA1c reduction","score":0.9089999794960022},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.9710000157356262},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7889999747276306},{"id":"https://openalex.org/keywords/systolic-blood-pressure","display_name":"systolic blood pressure","score":0.9490000009536743},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9760000109672546},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.859000027179718},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.38999998569488525}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.9930013418197632},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9376453161239624},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.7078198194503784},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6847261786460876},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.6410849094390869},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6325918436050415},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6180918216705322},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.5757510662078857},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5465927720069885},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5228310227394104},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5172817707061768},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.45044010877609253},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.42209678888320923},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4174532890319824},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3276939392089844},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.22348248958587646},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.3810/pgm.2010.05.2149","doi":"https://doi.org/10.3810/pgm.2010.05.2149","is_oa":false,"landing_page_url":"https://doi.org/10.3810/pgm.2010.05.2149","pdf_url":null,"source":{"id":"https://openalex.org/S11800902","display_name":"Postgraduate Medicine","issn_l":"0032-5481","issn":["0032-5481","1941-9260"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Postgraduate Medicine","raw_type":"journal-article"},{"id":"pmid:20463421","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20463421","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Postgraduate medicine","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307768","display_name":"Amylin Pharmaceuticals","ror":"https://ror.org/043cec594"},{"id":"https://openalex.org/F4320307776","display_name":"Merck","ror":"https://ror.org/02891sr49"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W22189248","https://openalex.org/W75245760","https://openalex.org/W1526927233","https://openalex.org/W1976287166","https://openalex.org/W1984740259","https://openalex.org/W1986085856","https://openalex.org/W1999701478","https://openalex.org/W1999843320","https://openalex.org/W2026228390","https://openalex.org/W2028272916","https://openalex.org/W2031723890","https://openalex.org/W2061244748","https://openalex.org/W2062883844","https://openalex.org/W2064967739","https://openalex.org/W2070710390","https://openalex.org/W2078090288","https://openalex.org/W2083534804","https://openalex.org/W2085912144","https://openalex.org/W2096539888","https://openalex.org/W2096733280","https://openalex.org/W2108646121","https://openalex.org/W2109728760","https://openalex.org/W2115638697","https://openalex.org/W2121414237","https://openalex.org/W2126781806","https://openalex.org/W2129377335","https://openalex.org/W2131278438","https://openalex.org/W2145053281","https://openalex.org/W2145279264","https://openalex.org/W2146901298","https://openalex.org/W2148798434","https://openalex.org/W2158666727","https://openalex.org/W2162934281","https://openalex.org/W2170872053","https://openalex.org/W2172488527","https://openalex.org/W2188846692","https://openalex.org/W2599408064","https://openalex.org/W2626017884","https://openalex.org/W3198570063","https://openalex.org/W4242344507"],"related_works":["https://openalex.org/W2974011125","https://openalex.org/W2767183956","https://openalex.org/W2087188090","https://openalex.org/W2784010323","https://openalex.org/W2162996901","https://openalex.org/W2084760284","https://openalex.org/W1579673112","https://openalex.org/W2129777004","https://openalex.org/W1984430136","https://openalex.org/W2078090288"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1],"objective":[2],"was":[3,65,169],"to":[4,48,67,205,214],"compare":[5],"the":[6,22,93,98,101,216,227],"treatment":[7,23,107,134,174],"effects":[8,217,231],"between":[9],"exenatide":[10,62,70,85,125,172,187,202,219],"and":[11,53,113,140,190,223,226],"insulin,":[12,91],"which":[13],"are":[14,212],"2":[15,26,43],"injectable":[16],"peptide":[17],"hormone-based":[18],"therapy":[19],"options":[20],"for":[21,46,207,229],"of":[24,80,165,186,218],"type":[25,42],"diabetes":[27,44],"mellitus.":[28],"METHODS:":[29],"Data":[30],"from":[31,83,119],"4":[32],"randomized,":[33],"open-label,":[34],"comparator-controlled":[35],"clinical":[36],"trials":[37],"in":[38,97],"1423":[39],"patients":[40,152],"with":[41,61,90,92,100,158,161,171,176],"followed":[45],"16":[47],"52":[49,195],"weeks":[50],"were":[51,192],"pooled":[52],"analyzed.":[54],"RESULTS:":[55],"At":[56],"26":[57],"weeks,":[58],"glycemic":[59,208],"control":[60],"(-1.2%":[63],"HbA1c)":[64],"non-inferior":[66,204],"insulin":[68,133,162,177,206],"(-1.1%;":[69],"vs":[71,126],"insulin;":[72,127],"P":[73,128],"=":[74],"0.09).":[75],"In":[76,131],"a":[77],"tertile":[78,99],"analysis":[79],"HbA1c":[81,104,189],"reduction":[82],"baseline,":[84],"induced":[86,108],"similar":[87],"reductions":[88,95],"compared":[89,157],"greatest":[94],"observed":[96],"highest":[102],"baseline":[103,120],"(9%-12.7%).":[105],"Exenatide":[106],"weight":[109,137,155,191],"loss":[110,156],"(-2":[111],"kg)":[112,139],"reduced":[114],"systolic":[115],"blood":[116,221],"pressure":[117,222],"(SBP)":[118],"(SBP,":[121],"-4.9":[122],"mm":[123,145],"Hg,":[124],"<":[129],"0.0001).":[130],"contrast,":[132],"increased":[135],"body":[136,224],"(1.8":[138],"decreased":[141],"SBP":[142],"by":[143],"-0.4":[144],"Hg.":[146],"Overall,":[147],"about":[148],"3-fold":[149],"more":[150],"exenatide-treated":[151],"(70%)":[153],"experienced":[154],"those":[159],"treated":[160],"(21%).":[163],"Occurrence":[164],"nocturnal":[166],"mild-to-moderate":[167],"hypoglycemia":[168],"lower":[170],"(15%)":[173],"than":[175],"(29%;":[178],"difference,":[179],"-14;":[180],"[95%":[181],"CI,":[182],"-18,":[183],"-9.8]).":[184],"Effects":[185],"on":[188,220,232],"sustained":[193],"at":[194],"weeks.":[196],"CONCLUSION:":[197],"These":[198],"findings":[199],"indicate":[200],"that":[201],"is":[203],"control.":[209],"Further":[210],"studies":[211],"warranted":[213],"explore":[215],"weight,":[225],"potential":[228],"long-term":[230],"cardiovascular":[233],"outcomes.":[234]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2118664840","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
